Article
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
24 Aug 2022
Abstract excerpt
There is increasing recognition that pathogenic germ line variants drive the development of hematopoietic cancers in many individuals. Currently, patients with hereditary hematologic malignancies (HHMs) receive similar standard therapies and hematopoietic stem cell transplant (HSCT) approaches as those with sporadic disease. We hypothesize that patients with myeloid malignancies and deleterious germ line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
